Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 180

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

The Biology Behind mTOR Inhibition in Sarcoma

Open access
Wan, Xiaolin, Helman, Lee J.·2007·The Oncologist

Abstract

Learning Objectives: After completing this course, the reader will be able to: Discuss the function of the mTOR pathway in cancer cell growth and survival.Describe the potential mechanism of targeting this pathway by rapamycin and its derivatives for cancer therapy.Summarize the clinical trials performed with mTOR inhibitors in the treatment of sarcomas and suggest the future clinical development of these inhibitors in the treatment of sarcomas. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1634/theoncologist.12-8-1007

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 180

Metadata

Authors
Wan, X., & Helman, L. J.
Venue
The Oncologist
Published
2007-08-01
Volume
12
Issue
8
Pages
1007-1018
ISSN
  • 1083-7159 (ISSN-L)
  • 1549-490X
OpenAlex
W2143393758
Cited by
180
References
10
FWCI
5.99
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Biology Behind mTOR Inhibition in Sarcoma. https://app.cochat.ai/papers/10.1634/theoncologist.12-8-1007
The paper
Wan, X., & Helman, L. J. (2007). The Biology Behind mTOR Inhibition in Sarcoma. The Oncologist. https://doi.org/10.1634/theoncologist.12-8-1007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.